BMRN(BMRN)
BMRN
Q4 2026 EPS Estimate
$1.38
Oct 26, 2026 · Reports after close
Revenue Estimate
$1.03B
FY2026E EPS$5.03
FY2027E EPS$6.62
Analyst Sentiment
Wall St. Consensus
Buy29 analysts·High coverage
70
Score
23 Buy (79%)6 Hold (21%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
2379%
Hold
621%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$59.00
-10.8%
Consensus
$97.50
+47.5%
Bull
$124.00
+87.5%
12-Month Target Range29 analysts
$59.00$97.50$124.00
Current $66.12Consensus
Current Price
$66.12
Upside to Consensus
$31.38
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+14.05%
EPS+31.56%
FY2028
Rev+7.92%
EPS+17.18%
FY2029
Rev+8.19%
EPS+13.99%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $3.91B | $4.45B | $4.81B | $5.20B | $5.50B |
| Low | $3.89B | $4.26B | $4.43B | $5.01B | $5.30B |
| High | $3.94B | $4.76B | $5.22B | $5.43B | $5.75B |
| EBITDA Avg | $535M | $610M | $659M | $712M | $753M |
| Low | $532M | $584M | $607M | $686M | $726M |
| High | $539M | $652M | $715M | $744M | $787M |
| EBIT Avg | $372M | $424M | $458M | $495M | $524M |
| Low | $370M | $406M | $422M | $477M | $504M |
| High | $375M | $453M | $497M | $517M | $547M |
| Net Income Avg | $993M | $1.29B | $1.49B | $1.74B | $1.89B |
| Low | $971M | $997M | $568M | $1.66B | $1.80B |
| High | $1.01B | $1.52B | $2.22B | $1.85B | $2.00B |
| EPS Avg | $5.03 | $6.62 | $7.75 | $8.84 | $9.57 |
| Low | $4.92 | $5.05 | $2.88 | $8.41 | $9.11 |
| High | $5.10 | $7.69 | $11.23 | $9.35 | $10.13 |
| Analysts (Rev / EPS) | 19 / 16 | 19 / 16 | 19 / 15 | 9 / 9 | 15 / 6 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $1.03B | $1.13B | $1.06B | $1.09B | $1.12B | $1.14B |
| Low | $988M | $1.10B | $1.03B | $1.06B | $1.08B | $1.11B |
| High | $1.06B | $1.15B | $1.10B | $1.13B | $1.16B | $1.18B |
| EBITDA Avg | $141M | $154M | $145M | $150M | $153M | $157M |
| Low | $135M | $150M | $141M | $145M | $148M | $152M |
| High | $145M | $157M | $150M | $155M | $158M | $162M |
| EBIT Avg | $98M | $107M | $101M | $104M | $107M | $109M |
| Low | $94M | $104M | $98M | $101M | $103M | $105M |
| High | $101M | $109M | $104M | $108M | $110M | $113M |
| Net Income Avg | $263M | $340M | $290M | $310M | $331M | $366M |
| Low | $223M | $305M | $278M | $297M | $317M | $351M |
| High | $287M | $367M | $303M | $324M | $345M | $382M |
| EPS Avg | $1.35 | $1.75 | $1.49 | $1.60 | $1.70 | $1.89 |
| Low | $1.15 | $1.57 | $1.43 | $1.53 | $1.63 | $1.81 |
| High | $1.48 | $1.89 | $1.56 | $1.67 | $1.78 | $1.97 |
| Analysts (Rev / EPS) | 14 / 11 | 14 / 11 | 9 / 4 | 7 / 4 | 7 / 7 | 13 / 4 |